Cholesterol Goals Established for Patients with Diabetes and Metabolic Syndrome
Dyslipidemia of Insulin Resistance Syndrome Explained; Need for Treatment to Reduce Risk Emphasized
Review of Clinical trial Data Reaffirms Safety of Statin Therapy
Protective Effects of HDL-C and Need to Raise Low Levels Explored
Risk Factors Common to Insulin Resistance and Atherosclerosis Explain Why Diabetes is a Cardiovascular Disease
Question and Answer
Heart Protection Study Finds Simvastatin Reduces Vascular Risk in a Wide Range of High-Risk Patients
Lipid-Lowering Therapy Stabilizes Plaque Reduces Events by Limiting Inflammation
New Cholesterol Guidelines Emphasize Risk Assessment
